Taylor Goodspeed advises health care and life sciences companies on regulatory compliance counseling, with an emphasis on the digital health industry and medical technology companies. She also represents health care clients in fraud and abuse matters in federal and state courts and state administrative agency proceedings.
Taylor defends health care providers in False Claims Act investigations and litigation brought by federal and state agencies and qui tam whistleblowers. She has counseled health systems and emerging companies on federal and state anti-kickback statutes, federal and state referral prohibitions, licensure requirements, and state corporate practice of medicine provisions. She has also structured various health care transactions.
Prior to joining Jones Day, she coauthored multiple publications on public attitudes towards noninvasive prenatal testing, such as cell-free fetal DNA technology.
Taylor maintains an active pro bono practice, serving on Jones Day's Anti-Human Trafficking Committee and on the American Hospital Association's (AHA) Human Trafficking Advisory Committee.
Taylor is a member of the American Health Lawyers Association and the California Society for Healthcare Attorneys.
Large digital health company grows operations across U.S.
Jones Day advised a large digital health company in expanding operations throughout multiple states in the U.S. and in responding to several state regulator inquiries regarding its operations.
- April 2018The Shifting Landscape of Organ Allocation for Transplantation
- University of Pennsylvania (J.D. 2017; Articles Editor, University of Pennsylvania Law Review; Master of Bioethics 2017, Perelman School of Medicine); Stanford University (B.A. in Human Biology 2012; B.A. in Classics 2012)